Our reputable Pharamceutical Microbiology conference returns for its 3rd installment on 20th and 21st January, 2014, London UK.
Pharmaceutical Microbiology 2014 will draw upon the experiences and knowledge from experts and specialists around the globe to provide first-class presentations and stimulating discussions.
The conference will aim to focus on the regulatory aspect, with topics addressing preparations for auditing, what to expect during the inspection process, and how to rectify poor situations. There will also be considerable spotlight on novel rapid methods, case studies from the USA, their implementation, and the current regulatory view on methods. Among these hot topics the event will also examine sterility assessment, risk management, and contamination control.
Key Benefits of Attending:
- Regulatory body representation and update – what to expect from inspection, how to prepare your lab, and how to rectify situations when things go wrong.
- Discover cutting edge rapid methods, how to implement the technology, and the regulatory stance
- Hear specialist advice on contamination control and risk management to minimise costs and maximise efficiency
- Learn about hot topics which include objectionable organisms, viral contaminations, update on the pharmacopeias, and quality by design.
- Discuss case studies and experiences with expert speakers and delegates from across the UK, USA, and Europe.
Plus an Interactive Post-Conference Workshop
Wednesday 22nd January 2014, Marriott Regents Park London, UK
Aseptic Behavior, Feedback & Learning
Workshop Leader: Phil Duncanson, Site Microbiologist & QC Lead, MedImmune
09.00 - 17.30
Key Speakers:
- Phil Duncanson, Site Microbiologist & QC Lead, MedImmune
- Mary-Anne Weatherhead, Qualified Person, Pfizer
- Andrew Bartko, Senior Scientist, Battelle
- William Wade, Professor of Oral Microbiology, Barts and The London
- Brendan Gilmore, Senior Lecturer in Pharmaceutical Microbiology, Queen’s University Belfast
- Amy McDaniel, Associate Director, Production Operations, Pfizer
- Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca
- Pierre Raboisson, Head of Medicinal Chemistry, Johnson & Johnson
- Olivier Chancel, Head of Pharmaceutical Support, Merial Sas (Sanofi)
- Di Morris, Consultant, Pharmaceutical Solutions Ltd. (ex-MHRA)
- Stephen Rawling, Microbiology Team Leader, GSK
- John Duguid, Principal Process Analytical Scientist, Genzyme
- Kim Bowers, Senior Supervisor, Pfizer
- Hilary Chan, Quality Scientist IV, Pfizer
- Erika Pfeiler, Microbiologist, FDA
- Steven Donald, Microbiologist, FDA
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
This event is unmissable for the following:
- Microbiologists
- Biological manufacture and production
- Quality Control
- Quality Assurance
- Antimicrobial and biocide research
- Biotech Research and Development
- Sterile lab management
- Validation and Regulatory affairs
- Sterile facilities design and construction
Venue
Marriott Hotel, Regents Park
128 King Henry's Road
London, NW3 3ST
United Kingdom
